A team of international researchers including Monash University academics has discovered that, contrary to previous belief, fructose causes liver toxicity by changing the barrier function of the intestine.
New research from Monash Institute of Pharmaceutical Sciences (MIPS), in collaboration with the Max Planck Institute, Mayo Clinic, University of Auckland, University of Essex and University of Tokyo, has uncovered new structures of protein
A new collaboration between MIPS researcher Professor Patrick Sexton’s team and the leading biological cryo-EM biotechnology product development company, Thermo Fisher Scientific, will bring cryo-electron microscopy of G protein-coupled
Researchers at the Monash Institute of Pharmaceutical Sciences (MIPS) and the ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (CBNS) have created a nanoparticle that could improve the properties of painkillers by delivering
Leading cardiovascular disease researcher Professor Rebecca Ritchie has been appointed as the new Theme Leader of the Drug Discovery Biology Theme in the Monash Institute of Pharmaceutical Sciences (MIPS).
The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.
PharmAlliance, the research, professional practice and education partnership between the Schools of Pharmacy at Monash University, University College London (UCL) and the University of North Carolina at Chapel Hill (UNC), has held its
The Monash Faculty of Pharmacy and Pharmaceutical Sciences has been awarded nearly $20 million dollars in research funding in the recent rounds of grants announced by the National Health and Medical Research Council (“NHMRC”) and the
Three researchers from the Drug Discovery Biology theme at the Monash Institute of Pharmaceutical Sciences have received prestigious awards from the British Pharmacological Society.